Xiaoyong Wei
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The efficacy and safety of PD-1 inhibitors combined with 125I seed implantation in treating extrahepatic metastasis of hepatocellular carcinoma.
Journal: Frontiers in medicine
Published: August 27, 2025
LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation.
Journal: Biology direct
Published: January 22, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial.
Journal: Signal transduction and targeted therapy
Published: January 18, 2025
Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter study.
Journal: Journal of Cancer
Published: January 21, 2024
Circular RNA circDNM3OS Functions as a miR-145-5p Sponge to Accelerate Cholangiocarcinoma Growth and Glutamine Metabolism by Upregulating MORC2.
Journal: OncoTargets and therapy
Published: October 28, 2020
MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
Journal: Stem cell research & therapy
Published: July 29, 2019
c[RGDyk]-coated liposomes loaded with adriamycin and miR-21 mimics inhibit the growth of hepatoma cell line SMCC-7721 via up-regulating Bax and p53.
Journal: Translational cancer research
Published: February 21, 2019
MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Journal: Molecular therapy. Nucleic acids
Published: December 12, 2018
miR‑21 inhibitor facilitates the anticancer activity of doxorubicin loaded nanometer in melanoma.
Journal: Oncology reports
Published: June 05, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026